Related references
Note: Only part of the references are listed.Cardiac toxicity in breast cancer survivors: Review of potential cardiac problems
Brian R. J. Healey Bird et al.
CLINICAL CANCER RESEARCH (2008)
A SAS program for calculating cumulative incidence of events (with confidence limits) and number at risk at specified time intervals with partially censored data
Alan D. Penman et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2008)
Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the north central cancer treatment group n9831 adjuvant breast cancer trial
Edith A. Perez et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on southwest oncology group protocol s8897
Patricia A. Ganz et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Left ventricular ejection fraction and cardiotoxicity: Is our ear really to the ground?
Michael S. Ewer et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Early breast cancer therapy and cardiovascular injury
Lee W. Jones et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer
Mary C. Pinder et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Trastuzumab treatment and the risk of central nervous system (CNS) metastases
M. C. Pinder et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: Cardiac and pulmonary late effects
Joseph R. Carver et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Long-term cardiac toxicity after adjuvant epirubicin-based chemotherapy in early breast cancer: French Adjuvant Study Group Results
P Fumoleau et al.
ANNALS OF ONCOLOGY (2006)
Chemotherapy and cardiotoxicity in older breast cancer patients: A population-based study
JJ Doyle et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Variation in modes of chemotherapy administration for breast carcinoma and association with hospitalization for chemotherapy-related toxicity
XLL Du et al.
CANCER (2005)
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Cardiovascular complications of cancer therapy - Diagnosis, pathogenesis, and management
ETH Yeh et al.
CIRCULATION (2004)
Postmarketing surveillance for drug safety: Surely we can do better
MR Griffin et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Participation of patients 65 years of age or older in cancer clinical trials
JH Lewis et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Adverse drug event monitoring at the Food and Drug Administration - Your report can make a difference
SR Ahmad
JOURNAL OF GENERAL INTERNAL MEDICINE (2003)
Early detection of toxicity and adjustment of ongoing clinical trials: The history and performance of the North Central Cancer Treatment Group's real-time toxicity monitoring program
RM Goldberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Timing of new black box warnings and withdrawals for prescription medications
KE Lasser et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Drug therapy - Side effects of adjuvant treatment of breast cancer
CL Shapiro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Patterns of use of chemotherapy for breast cancer in older women: Findings from Medicare claims data
XL Du et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Completeness of safety reporting in randomized trials - An evaluation of 7 medical areas
JPA Ioannidis et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Epidemiological assessment of drug-induced disease
DW Kaufman et al.
LANCET (2000)
Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer:: The International Breast Cancer Study Group Trial VII
D Crivellari et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
